MANH vs PATH · P/E 57, rev $1.04B vs P/E 19, rev $1.61B
Manhattan Associates Inc (MANH) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Manhattan Associates Inc (MANH) is a software - application company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MANH revenue for 2024-12-31 was $1.04B. Net income was $218.4M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. MANH currently screens at market cap $12.14B and trailing P/E 57.1.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MANH currently screens at market cap $12.14B and trailing P/E 57.1. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MANH and PATH stock pages for the full models.
Not investment advice.